EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Therapeutic Potential of Adipose-Derived Mesenchymal Stem Cell Secretome in Osteoarthritis: A Comprehensive Study

Elsa González-Cubero, Maria Luisa González-Fernández, Marta Esteban-Blanco iD, Saúl Pérez-Castrillo, Esther Pérez-Fernández, Nicolás Navasa iD, Ana M Aransay iD, Juan Anguita iD, Vega Villar-Suárez iD

International Journal of Molecular Sciences · 20.10.2024 · 25 (20) · 11287

DOI: 10.3390/ijms252011287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.10.2024. Verfasst von Elsa González-Cubero und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Stanford School of Medicine, Stanford University, Palo Alto, CA 94304, USA. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteoarthritis, Chondrocytes, Secretome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MINISTERIO DE CIENCIA E INNOVACIÓN, MCIN/AEI/10.13039/501100011033, Regional Government of Castile and León (Spain).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage degradation and inflammation. This study investigates the therapeutic potential of secretome derived from adipose tissue mesenchymal stem cells (ASCs) in mitigating inflammation and promoting cartilage repair in an in vitro model of OA. Our in vitro model comprised chondrocytes inflamed with TNF. To assess the therapeutic potential of secretome, inflamed chondrocytes were treated with it and concentrations of pro-inflammatory cytokines, metalloproteinases (MMPs) and extracellular matrix markers were measured. In addition, secretome-treated chondrocytes were subject to a microarray analysis to determine which genes were upregulated and which were downregulated. Treating TNF-inflamed chondrocytes with secretome in vitro inhibits the NF-κB pathway, thereby mediating anti-inflammatory and anti-catabolic effects. Additional protective effects of secretome on cartilage are revealed in the inhibition of hypertrophy markers such as RUNX2 and COL10A1, increased production of COL2A1 and ACAN and upregulation of SOX9. These findings suggest that ASC-derived secretome can effectively reduce inflammation, promote cartilage repair, and maintain chondrocyte phenotype. This study highlights the potential of ASC-derived secretome as a novel, non-cell-based therapeutic approach for OA, offering a promising alternative to current treatments by targeting inflammation and cartilage repair mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsOsteoarthritisChondrocytesSecretomeAdipose TissueSOX9 Transcription FactorHumansCore Binding Factor Alpha 1 SubunitNF-kappa BCollagen Type IICollagen Type XAggrecansCells, CulturedTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

conditioned mediuminflammatory cytokinesmesenchymal stem cellsosteoarthritissecretome

Substanzen

SOX9 Transcription FactorCore Binding Factor Alpha 1 SubunitNF-kappa BSOX9 protein, humanCollagen Type IIACAN protein, humanCollagen Type XCOL10A1 protein, humanRUNX2 protein, humanCOL2A1 protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, Stanford School of Medicine, Stanford University, Palo Alto, CA 94304, USA.
  • Department of Anatomy, Faculty of Veterinary Sciences, Campus de Vegazana, University of Léon-Universidad de León, 24071 León, Spain.
  • Department of Molecular Biology, Faculty of Veterinary Sciences, Campus de Vegazana, University of Léon-Universidad de León, 24071 León, Spain.
  • Center for Cooperative Research in Biosciences (CIC bioGUNE)-Basque Research and Technology Alliance (BRTA), Parque Tecnológico de Bizkaia, Building 801-A, 48160 Derio, Spain.
  • CIBERehd, ISCIII, 28029 Madrid, Spain.
  • IKERBASQUE, Basque Foundation for Science, 48011 Bilbao, Spain.

ORCID-Profile: Marta Esteban-Blanco, Nicolás Navasa, Ana M Aransay, Juan Anguita, Vega Villar-Suárez

Förderung

  • MINISTERIO DE CIENCIA E INNOVACIÓN
  • MCIN/AEI/10.13039/501100011033
  • Regional Government of Castile and León (Spain)

Zitieren

APA

González-Cubero, E., González-Fernández, M. L., Esteban-Blanco, M., Pérez-Castrillo, S., Pérez-Fernández, E., Navasa, N., Aransay, A. M., Anguita, J., & Villar-Suárez, V. (2024). The Therapeutic Potential of Adipose-Derived Mesenchymal Stem Cell Secretome in Osteoarthritis: A Comprehensive Study. International Journal of Molecular Sciences, 25(20), 11287. https://doi.org/10.3390/ijms252011287

Vancouver

González-Cubero E, González-Fernández ML, Esteban-Blanco M, Pérez-Castrillo S, Pérez-Fernández E, Navasa N, et al. The Therapeutic Potential of Adipose-Derived Mesenchymal Stem Cell Secretome in Osteoarthritis: A Comprehensive Study. International Journal of Molecular Sciences. 2024;25(20):11287. doi:10.3390/ijms252011287

BibTeX
@article{GonzlezCubero2024,
  author = {González-Cubero, Elsa and González-Fernández, Maria Luisa and Esteban-Blanco, Marta and Pérez-Castrillo, Saúl and Pérez-Fernández, Esther and Navasa, Nicolás and Aransay, Ana M and Anguita, Juan and Villar-Suárez, Vega},
  title = {The Therapeutic Potential of Adipose-Derived Mesenchymal Stem Cell Secretome in Osteoarthritis: A Comprehensive Study},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {20},
  pages = {11287},
  doi = {10.3390/ijms252011287}
}
Kostenlos starten →